| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Prepaid expenses and other current assets | 4,116 | |||
| Cash and cash equivalents | 53,583 | |||
| Total current assets | 57,699 | |||
| Total assets | 57,699 | |||
| Accrued expenses and other | 636,632 | |||
| Loan payable | 200,000 | |||
| Accrued compensation | 4,011,998 | |||
| Accrued consulting | 787,903 | |||
| Accounts payable | 133,808 | |||
| Total current liabilities | 5,770,341 | |||
| Convertible notes, net | 1,428,880 | |||
| Total liabilities | 7,199,221 | |||
| Accumulated deficit | -9,191,668 | |||
| Preferred stock, value-Series BPreferred Stock | 1 | |||
| Preferred stock, value-Series APreferred Stock | 0 | |||
| Preferred stock, value | 0 | |||
| Common stock, 0.00001 par value 100,000,000 shares authorized 7,242,137 shares issued and outstanding | 72 | |||
| Additional paid-in capital | 2,050,073 | |||
| Total stockholders deficit | -7,141,522 | |||
| Total liabilities and stockholders deficit | 57,699 | |||
Mosaic ImmunoEngineering Inc. (CPMV)
Mosaic ImmunoEngineering Inc. (CPMV)